Delivery Order SPE2DR25D1100-SPE2DR26FDB5L
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,932.71 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, and will be fulfilled at the company's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $61,117.01 by the Defense Logistics Agency on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for January 13, 2026. This delivery order is executed under...
- Amerisourcebergen Drug Corp, a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $48,044.83 on January 21, 2026, by the Defense Logistics Agency for the supply of REPATHA 140 mg/mL SureClick auto-injector medication. This competitive, firm fixed-price delivery order is scheduled for completion by January 22, 2026, and represents a task order issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 17, 2025, for REPATHA 140 mg/mL SureClick auto-injector pharmaceutical products. The delivery order, valued at $9,661.02, represents a firm fixed-price contract with an ultimate completion date of November 18, 2025. This award was competitively awarded with no set-aside designation and functions as a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,081.08 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract employs firm fixed price pricing and carries an ultimate completion date of September 3, 2025, with performance to be executed at the contractor's Conshohocken, PA facility. This delivery order represents...
- AmerisourceBergen Drug Corp was awarded a $2,543.51 delivery order by the Defense Logistics Agency (DLA) on December 2, 2025, for the supply of REPATHA 140 mg/ml SureClick autoinjectors, with a completion date of December 3, 2025. This non-competitive delivery order, issued under firm fixed pricing, represents a direct fulfillment under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,880.79 by the Defense Logistics Agency on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract, issued under a firm fixed price arrangement, covers the supply of Repatha 140 mg/ml SureClick auto-injectors. This delivery order was competitively awarded with no set-aside designation and represents a child award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,971.95 firm fixed-price delivery order from the Defense Logistics Agency on January 15, 2026, for Repatha 140 mg/ml SureClick auto-injectors. The award is unset-aside and competitively awarded, with an ultimate completion date of January 16, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $41,759.43 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is the vendor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDB5LDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,655.44 by the Defense Logistics Agency on January 23, 2026, for REPATHA 140 mg/ml SureClick auto-injectors. The contract, with an ultimate completion date of January 26, 2026, is a non-set-aside competitive award. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the company's comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., which holds the parent Indefinite Delivery Contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. The delivery of REPATHA, a prescription medication used for cholesterol management, supports the Defense Health Agency and military treatment facilities. DLA Troop Support Medical is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, demonstrating the strategic importance of pharmaceutical supply chain management for federal military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/22/26 |